PGI2 USE OF DIFFERENT STATISTICAL APPROACHES TO COMPARE REAL-WORLD OUTCOMES ASSOCIATED WITH VEDOLIZUMAB VERSUS INFLIXIMAB IN BIOLOGIC-NAIVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE

May 1, 2019, 00:00
10.1016/j.jval.2019.04.773
https://www.valueinhealthjournal.com/article/S1098-3015(19)30965-9/fulltext
Title : PGI2 USE OF DIFFERENT STATISTICAL APPROACHES TO COMPARE REAL-WORLD OUTCOMES ASSOCIATED WITH VEDOLIZUMAB VERSUS INFLIXIMAB IN BIOLOGIC-NAIVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30965-9&doi=10.1016/j.jval.2019.04.773
First page :
Section Title :
Open access? : No
Section Order : 10357
Categories :
Tags :
Regions :
ViH Article Tags :